Document ID: chunk:federal_register_of_legislation:F2021L01162:reg:9:p6
Version: federal_register_of_legislation:F2021L01162
Segment Type: reg
Provision Reference: reg 9 (pt 6/6)
Character Range: 17773–19953

(45)      having exogenous lipoid pneumonitis at the time of the clinical worsening of fibrosing interstitial lung disease;
Note: exogenous lipoid pneumonitis is defined in the Schedule 1 - Dictionary.
(46)      having tropical pulmonary eosinophilia for at least the 6 months before the clinical worsening of fibrosing interstitial lung disease;
Note: tropical pulmonary eosinophilia is defined in the Schedule 1 - Dictionary.
(47)      having gastro-oesophageal reflux disease for at least the 5 years before the clinical worsening of fibrosing interstitial lung disease;
(48)      inhaling a vapour, gas, dust or fumes produced by a substance from the specified list of substances, or smoke from fire, in an enclosed space:
(a)          for a cumulative period of at least 5,000 hours before the clinical worsening of fibrosing interstitial lung disease; and
(b)          if that exposure has ceased before the clinical worsening of fibrosing interstitial lung disease, then that worsening occurred within 20 years of cessation;
Note: specified list of substances is defined in the Schedule 1 - Dictionary.
(49)      inhaling a vapour, gas, dust or fumes produced by a substance from the specified list of substances, or smoke from fire, in an open environment:
(a)          for a cumulative period of at least 10,000 hours before the clinical worsening of fibrosing interstitial lung disease; and
(b)          if that exposure has ceased before the clinical worsening of fibrosing interstitial lung disease, then that worsening occurred within 20 years of cessation;
Note: specified list of substances is defined in the Schedule 1 - Dictionary.
(50)      inhaling smoke from the combustion of wood, charcoal, coal or other biomass or fossil fuel, in an enclosed space:
(a)          for a cumulative period of at least 5,000 hours before the clinical worsening of fibrosing interstitial lung disease; and
(b)          if that exposure has ceased before the clinical worsening of fibrosing interstitial lung disease, then that worsening occurred within 20 years of cessation;
(51)      inability to obtain appropriate clinical management for fibrosing interstitial lung disease.